InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-10-24 | Marjorie Taylor Greene | house | Purchase | $1,001 - $15,000 |
| 2025-05-14 | Marjorie Taylor Greene | house | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan(R-PA08) | house | Purchase | $1,001 - $15,000 |
| 2025-03-17 | Marjorie Taylor Greene | house | Purchase | $1,001 - $15,000 |
| 2025-01-21 | Marjorie Taylor Greene | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $222.58B-1.9% | $226.83B+10.7% | $204.98B+13.0% | $181.33B |
| Cost of products sold | $214.41B-2.3% | $219.41B+10.8% | $198.10B+13.3% | $174.84B |
| Gross margin | $8.17B+10.2% | $7.41B+7.9% | $6.87B+6.0% | $6.48B |
| Distribution, selling, general, and administrative expenses | $5.38B+7.6% | $5.00B+4.2% | $4.80B | — |
| Restructuring and employee severance | $88.0M-49.7% | $175.0M+84.2% | $95.0M-5.9% | $101.0M |
| Amortization and other acquisition-related costs | $464.0M+63.4% | $284.0M-0.4% | $285.0M-12.0% | $324.0M |
| Acquisition-related cash and share-based compensation costs [Line Items] | $126.0M | $0 | $0 | — |
| Impairments and (gain)/loss on disposal of assets, net | $18.0M-97.2% | $634.0M-49.1% | $1.25B-39.5% | $2.06B |
| Litigation (recoveries)/charges, net | -$185.0M-337.2% | $78.0M+125.7% | -$304.0M-423.4% | $94.0M |
| Operating earnings | $2.27B+83.0% | $1.24B+65.3% | $752.0M | — |
| Other (income)/expense, net | -$41.0M-355.6% | -$9.0M-280.0% | $5.0M-77.3% | $22.0M |
| Interest expense, net | $215.0M+321.6% | $51.0M-39.3% | $84.0M-42.9% | $147.0M |
| Earnings before income taxes | $2.10B+74.9% | $1.20B+81.1% | $663.0M | — |
| Income Tax Expense (Benefit) | $532.0M+52.9% | $348.0M+4.8% | $332.0M | — |
| Net earnings | $1.57B+83.9% | $853.0M+157.7% | $331.0M | — |
| Less: Net earnings attributable to noncontrolling interests | -$8.0M-700.0% | -$1.0M+0.0% | -$1.0M+0.0% | -$1.0M |
| Net earnings attributable to Cardinal Health, Inc. | $1.56B+83.2% | $852.0M+158.2% | $330.0M | — |
| Basic (in dollars per share) | $6.5M+86.2% | $3.5M+174.0% | $1.3M+137.7% | -$3.4M |
| Diluted (in dollars per share) | $6.5M+87.0% | $3.5M+173.8% | $1.3M+137.4% | -$3.4M |
| Basic (in shares) | $241.0M-1.6% | $245.0M-6.1% | $261.0M-6.5% | $279.0M |
| Diluted (in shares) | $242.0M-2.0% | $247.0M-5.7% | $262.0M-6.1% | $279.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Cardinal (CAH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Jim Cramer on Cardinal: “Gotta Put That One Behind”
Cardinal Health Among 9 Companies To Announce Dividend Increases In The First Half Of May